A short video from Now This on my campaign. It highlights my interview from the RNC in Cleveland and ideas on Universal Basic Income:
Category: transhumanism – Page 116
Living Forever Has Never Been More Popular
My dispatch for Vice from the recent successful RAAD Festival—a giant gathering of longevity enthusiasts:
In less than a month, I’ll mark the two-year anniversary to my presidential campaign for the Transhumanist Party. My run for the White House was never about winning, but spreading the idea that Americans can achieve indefinite lifespans through science and technology—if only the government were to help out and put significant resources into the anti-aging field.
While the US government still hasn’t shown much interest in supporting longevity research for its citizens, the life extension movement is dramatically expanding around the world. Two years ago, the idea of speaking to 1000 longevity advocates in the same convention hall was a pipe dream. Most transhumanist conferences could barely get 100 people in the same room.
Last weekend in San Diego, that all changed. Billed as the biggest life extension festival in history, RAAD Fest took place from August 4–7. Over 1000 participants made it to the sold-out event, making it the largest group of transhumanists and longevity activists ever to assemble in one place.
The success of the festival signals the growing trend of the life extension movement. In the last few years, major companies like Google’s Calico and Human Longevity Inc. have formed to combat aging. Additionally, billionaires like Peter Thiel and Larry Ellison have funded longevity and anti-aging initiatives. Even Facebook founder Mark Zuckerberg recently called for science to end all disease this century.
Bionic Bird drone looks and flies just like a bird
Click on photo to start video.
This drone looks and flies just like a bird.
AI for President
This is a comprehensive and critical write-up on some of my policies by some leading researchers and thinkers. It’s from the magazine website of the IEEE, the world’s largest professional organization devoted to engineering and the applied sciences. Naturally, people in the field of science and engineering are some of the most difficult to please, since they are such critical thinkers (which is precisely why I like them so much):
When a transhumanist runs for president, what does that mean for society?
Facebook Live: Deus Ex 3D Printed Bionic Arm
Open Bionics prosthetic arm.
We’re live with Open Bionics and we’re checking out their insanely cool Deus Ex prosthetic arm.
Turned off by Trump and Clinton? Vote for a Transhumanist for President!
A new story by Scientific American on transhumanism: http://blogs.scientificamerican.com/cross-check/turned-off-b…resident/#
Transhumanist candidate Zoltan Istvan urges spending less on war and more on the scientific quest to defeat death.
I stopped by the NYC office today and chatted with veteran science writer John Horgan live on their Facebook page about transhumanism and my campaign
We covered lots of topics:
Live conversation with Zoltan Istvan and John Horgan about transhumanism, AI in government and preparing for the robotic age. Post your questions in the comments below.
Zoltan Istvan, Transhumanist Party Presidential Candidate
This has been a top trending video on SF Gate (the San Francisco Chronicle’s main website) for a few days now: http://video.sfgate.com/Zoltan-Istvan-Transhumanist-Party-Pr…e-31214223 The story is here and was also shared by Drudge Report: http://www.sfchronicle.com/opinion/openforum/article/Chip-en…694149.php
Biohacker says the U.S. Needs a Science Party Source: SFGate.com
Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare
Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.
“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”
As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.
With the emergence of such trends including: personalization of medicine on an “n-of-1” basis, adaptive clinical design, globalization of health care training, compassionate use legislative initiatives for experimental therapies, wider acceptance of complementary medical technologies, and the growth of international medical travel, patients and clinicians are more than ever before, exploring the ability to access the therapies of tomorrow, today.
The estimate of the current market size for procedural medical travel, defined by medical travelers who travel across international borders for the purpose of receiving medical care, is in the range of US $40–55 billion.
Additionally, major clinical trial gaps currently exist across all therapeutic segments that are responsible for human suffering and death. Cancer is one prime example. As a leading cause of morbidity and mortality worldwide for many decades, today there are approximately 14 million new cases diagnosed each year, with over 8 million cancer related deaths annually. It is estimated that less than 5% of these patients, take the initiative to participate in any available clinical studies.
“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Dr. Joel Osorio, Chief of Clinical Development RegenerAge SAPI de CV. “The ability to merge cellular and biologic approaches represents the next step in achieving comprehensive regeneration and disease reversion events in a range of chronic diseases responsible for human suffering and death.”
About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.
About RegenerAge SAPI de CV
RegenerAge SAPI de CV is a novel clinical company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.